← Open Payments lookup

CATHERINE DANG: Open Payments

NPI 1528715943 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$297 in 7 payments from 5 companies in 2025. Trend: 2023 $194 · 2024 $60 · 2025 $297

Food & beverage: $297
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc1$149
Neurocrine BioSciences, Inc.2$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$51
Supernus Pharmaceuticals, Inc.1$22
Luye Pharma (USA) Ltd.1$15

Products named: INVEGA SUSTENNA, INGREZZA, CAPLYTA, Qelbree, ERZOFRI EXTENDED-RELEASE.

Industry payments across CA — which companies pay providers there.